pegintron
Pegintron (Peginterferon Alfa-2b) is a medication used to treat Brain Neoplasms, Renal Cell Carcinoma, Cryoglobulinemia, Hepatitis D.
Peginterferon Alfa-2b · by Schering
Key facts
- Active ingredient
- Peginterferon Alfa-2b
- Form
- Injectable
- Strength
- Peginterferon ALFA-2B 120UG/0.5ML · Peginterferon ALFA-2B 150UG/0.5ML · Peginterferon ALFA-2B 50UG/0.5ML · Peginterferon ALFA-2B 80UG/0.5ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- brain neoplasms, renal cell carcinoma, cryoglobulinemia
- Manufacturer
- Schering
- FDA application
- BLA103949
May treat (source: NIH RxClass)
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Pegintron treat?
- Pegintron (Peginterferon Alfa-2b) may be used to treat brain neoplasms, renal cell carcinoma, cryoglobulinemia, hepatitis d, hemangioma, hepatocellular carcinoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Pegintron?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Pegintron. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Pegintron?
- Pegintron is marketed by Schering. You can see Schering's full profile, rating, and other products on pharmaranks.
- Is Pegintron a brand-name or generic drug?
- Pegintron is a brand-name product with the active ingredient Peginterferon Alfa-2b.
- Is Pegintron available over the counter?
- No. Pegintron is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Pegintron come in?
- Pegintron is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Pegintron FDA-registered?
- Pegintron is on record with the U.S. FDA under application number BLA103949. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about PEGINTERFERON ALFA-2B
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 4,645 reports naming PEGINTERFERON ALFA-2B — the active ingredient in Pegintron, and the FDA flagged 93% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- anaemia855 reports
- rash558 reports
- nausea441 reports
- fatigue381 reports
- white blood cell count decreased335 reports
- haemoglobin decreased314 reports
- decreased appetite308 reports
- neutrophil count decreased244 reports
Read these as a signal, not a rate. A report does not mean PEGINTERFERON ALFA-2B caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Pegintron head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
pegintron
New